Media

Fierce Biotech covers Shasqi Series B

November 11, 2021

Shasqi snatches $50M for chemotherapy-boosting treatments thanks to Arcus, NGM execs

“Shasqi prides itself on being a company of many firsts” writes Emmy Lucas, editorial intern at Fierce, covering healthcare, biotech and pharma.

Read the full article here